Alyeska Investment Group’s Marker Therapeutics MRKR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$326K	Sell	213,020 -48,757	-19%	-$74.6K	﹤0.01%	529
2025 Q1	$322K	Sell	261,777 -653,814	-71%	-$804K	﹤0.01%	476
2024 Q4	$38.5M	Buy	+915,591	New	+$38.5M	0.14%	175